Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01804023 · ClinicalTrials.gov registry record

Biomarkers of Protocol Compliance and Product Adherence

A clinical trial of HIV Prevention, sponsored by CONRAD.

Completed
Registry status
40
Enrollment target
1
Study location

NCT01804023 is a study of HIV Prevention that has completed, run by CONRAD. The registered enrollment target is 40 participants, below the 381-participant average among 32 other HIV Prevention trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01804023, a study of HIV Prevention, has completed, sponsored by CONRAD.

COMPLETED
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare tests of vaginal insertion of applicators(visual inspection of returned applicators (VIRA), inspection of returned applicators under ultraviolet (UV) light, and DNA/protein markers) to determine which, if any, warrant use in a clinical trial of a new vaginal microbicide. The study will also determine whether indicators of semen can be detected on applicators and the degree to which they correlate with reported intercourse, and the correlation between vaginal bacteria detected by a vaginal swab and those detected from the applicator. In addition, the study will determine whether several factors that may be encountered in a clinical trial are likely to affect detection of these markers, including storage for 30 days vs. 7 days, wiping applicators after use, the presence of gel, and inter- and intra-woman variability. The study will also assess safety.

Conditions Studied

HIV Prevention

Interventions

  • OTHER HEC placebo gel applicators

Study Locations (1)

Virginia

  • Clinical Research Center, Eastern Virginia Medical School - Norfolk

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-03
Est. Completion 2013-09

Sponsor

CONRAD

33 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01804023

The ClinicalTrials.gov registry entry for NCT01804023 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 381-participant average among 32 other HIV Prevention trials with a reported enrollment target (90% lower). The listed sponsor is CONRAD, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which HEC placebo gel applicators is the first listed.

NCT01804023 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01804023 about?

NCT01804023 is a clinical study titled "Biomarkers of Protocol Compliance and Product Adherence". The purpose of this study is to compare tests of vaginal insertion of applicators(visual inspection of returned applicators (VIRA), inspection of returned applicators under ultraviolet (UV) light, and DNA/protein markers) to determine which, if any, warrant use in a clinical trial of a new vaginal m...

What is the current status of trial NCT01804023?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-03. Estimated completion is 2013-09.

What conditions does trial NCT01804023 study?

This clinical trial studies the following conditions: HIV Prevention.

What interventions are being tested in trial NCT01804023?

The interventions under investigation include: HEC placebo gel applicators (OTHER).

Who is sponsoring clinical trial NCT01804023?

This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01804023 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Prevention

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.